Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia
Intravenous Dexmedetomidine Reduces Hypotension and Epigastric Pain in Cesarean Section Under Spinal Anesthesia: A Randomized Clinical Study
Sponsor: Egyptian Biomedical Research Network
This PHASE3 trial investigates Cesarean Section Complications and is currently completed. Egyptian Biomedical Research Network leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2020 — Aug 2020 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
May 2020 — Jun 2020 [monthly]
Completed PHASE3
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Egyptian Biomedical Research Network
For direct contact, visit the study record on ClinicalTrials.gov .